SOFITUZUMAB VEDOTIN
UNII 2X3CKG601L

Substance Identification & Data

This profile provides standardized clinical and technical data for Sofituzumab Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2X3CKG601L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1418200-58-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2X3CKG601L

CAS Registry Number

1418200-58-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SOFITUZUMAB VEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C106119

National Cancer Institute reference terminology for clinical and research data.

INN ID

9861

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-157

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sofituzumab Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SOFITUZUMAB VEDOTIN

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-(HOMO SAPIENS MUC16 (MUCIN 16, MUC-16, CANCER ANTIGEN 125, CA125)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E

SOFITUZUMAB VEDOTIN [INN]

SOFITUZUMAB VEDOTIN [USAN]

SOFITUZUMAB VEDOTIN [WHO-DD]